As the international community converges for the 26th International AIDS Conference (AIDS 2026), the World Health Organization (WHO) has unveiled a comprehensive progress report on the Global Health Sector Strategies (GHSS) for HIV, viral hepatitis, and sexually transmitted infections (STIs) covering the 2022–2030 period. The report serves as a diagnostic tool for the global health architecture, offering a sobering, data-driven look at the path toward eliminating these three major public health threats by the end of the decade.
The findings are bifurcated: while the world has demonstrated an extraordinary capacity for clinical and scientific success, the momentum is being critically undermined by systemic fragility, funding volatility, and persistent health inequities.
Main Facts: A Dual Narrative of Resilience and Regression
The WHO report characterizes the current state of the global response as a "tale of two stories." On one hand, the expansion of life-saving interventions has kept millions alive and prevented millions of new infections. On the other, the resurgence of specific infectious threats and the plateauing of critical prevention programs suggest that the goal of ending these epidemics by 2030 is under significant threat.
The strategy, adopted by the World Health Assembly in 2022, was designed as a common framework to align national policies with global targets. However, as the world passes the halfway point of the 2022–2030 cycle, the data reveals that while technical solutions exist, the delivery mechanisms—health systems, financing, and social support structures—are increasingly strained.
Chronology of the Response: From 2010 to the 2026 Milestone
To understand the current impasse, one must look at the trajectory of these diseases over the last decade and a half:
- 2010–2020: The Era of Rapid Expansion. During this decade, global health initiatives saw unprecedented success. HIV-related deaths plummeted as antiretroviral therapy (ART) became widely available, and global awareness campaigns for hepatitis and STIs began to gain traction in national policy frameworks.
- 2015: The Hepatitis Benchmark. This year serves as the baseline for the current hepatitis targets. Since then, the world has seen a 32% reduction in new hepatitis B infections, marking a significant victory for vaccination programs.
- 2022: Adoption of the GHSS. The World Health Assembly solidified the 2022–2030 roadmap, setting the stage for the integrated approach currently being championed by the WHO.
- 2025: The Funding Cliff. A critical turning point occurred last year when international donor funding for HIV prevention, particularly for pre-exposure prophylaxis (PrEP), saw a marked decline. This disruption has had a direct, negative impact on the accessibility of preventative care in low- and middle-income countries.
- 2026: The Current Assessment. Released during AIDS 2026 and coinciding with the lead-up to World Hepatitis Day (July 28), this report acts as a "mid-term exam" for the global health community, providing evidence to support the recent United Nations High-Level Meeting Political Declaration on HIV/AIDS.
Supporting Data: By the Numbers
The report’s strength lies in its granular data, which provides an unvarnished look at where the global response stands:
HIV/AIDS
- The Successes: By the end of 2025, 32 million people were receiving HIV treatment. Since 2010, new infections have dropped by 42%, and AIDS-related deaths have fallen by 57%.
- The Gaps: 9 million people currently lack access to life-saving treatment. New infections are rising among key populations—specifically men who have sex with men, sex workers, people who inject drugs, transgender individuals, and those within the prison system.
Viral Hepatitis
- The Successes: Global deaths related to hepatitis C have fallen by 12% since 2015.
- The Gaps: Hepatitis remains one of the world’s deadliest infectious diseases, claiming 1.3 million lives in 2024 alone. Disturbingly, deaths linked to hepatitis B have risen by 17% since 2015, highlighting a massive failure in diagnostic and treatment coverage.
Sexually Transmitted Infections (STIs)
- The Trends: Progress is inconsistent. While syphilis screening in pregnancy has improved, the overall incidence of STIs is on the rise in multiple regions.
- The Challenge: The rise of antimicrobial resistance (AMR), particularly concerning for gonorrhea, is threatening the efficacy of current treatment regimens. HPV vaccination coverage remains suboptimal, leaving millions vulnerable to cervical cancer.
Official Responses: A Call for Integrated Systems
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, did not mince words regarding the implications of the report. "This report tells two stories," he stated. "It demonstrates what is possible when countries invest in health, communities, and science. But it also shows how quickly progress can be undone with funding disruptions, humanitarian emergencies, and persistent inequalities."
Dr. Tedros emphasized that the next five years must be defined by the creation of "integrated, resilient health systems." The strategy moving forward is not to treat these diseases in silos, but to embed them within the broader primary health care framework.
Supporting this, Dr. Tereza Kasaeva, Director of the WHO’s Department for HIV, TB, Hepatitis, and STIs, framed the report as a tactical document. "This assessment is more than a progress report; it is a practical guide for action," she noted. She highlighted the release of the new Consolidated HIV Service Delivery Guidelines and HIV Surveillance Guidance as vital tools for countries struggling to organize their health responses.
Implications: The Strategic Path Forward
The report outlines several key priorities for the remainder of the 2030 strategy period. These are not merely suggestions but urgent requirements for any nation hoping to meet its international commitments:
1. Integration is the New Standard
The most successful national health responses are those that have moved away from disease-specific silos. By delivering HIV, hepatitis, and STI services alongside maternal health, tuberculosis programs, and noncommunicable disease screenings, countries can achieve greater reach and efficiency.
2. Eliminating Mother-to-Child Transmission
A major priority remains the validation of elimination for mother-to-child transmission of HIV, syphilis, and hepatitis B. This is a "low-hanging fruit" for global health—when maternal health services are properly integrated, the vertical transmission of these diseases can be largely eradicated.
3. Embracing Digital and Scientific Innovation
The integration of digital health, interoperable surveillance systems, and multi-disease testing platforms is essential. Furthermore, the introduction of innovative prevention technologies, such as twice-yearly injectable lenacapavir for HIV and doxycycline post-exposure prophylaxis (doxycycline PEP) for bacterial STIs, provides new ammunition in the fight. These tools must be distributed equitably, not just in high-income nations.
4. Centering Community Leadership
The WHO report emphasizes that top-down approaches are insufficient. By embedding community-generated data into national monitoring systems, countries can ensure accountability and verify that services are reaching those who are "furthest behind." Community leadership is identified as the best defense against the erosion of services caused by funding cuts or shifting political priorities.
Conclusion: A Turning Point for 2030
As the global health community looks toward 2030, the message from the WHO is clear: the technical ability to end these epidemics exists. However, the political and financial will to maintain that momentum is wavering.
The report serves as a stark reminder that in the absence of consistent funding and robust, integrated health systems, the hard-won gains of the last 15 years could be reversed. The upcoming World Hepatitis Day theme, "Hepatitis: Let’s Break It Down," serves as a fitting metaphor for the broader challenge: breaking down the financial, social, and systemic barriers that currently stand between millions of people and their right to health.
The next five years will be the true test of the international community’s commitment to these goals. By utilizing the new guidelines provided by the WHO and doubling down on integrated primary care, nations have a window of opportunity to reverse the stalling trends and move toward a future where HIV, viral hepatitis, and STIs no longer constitute a threat to global public health.
About the Author
